Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Musellim, F. Zuhur, G. Ongen, I. Ozdemir, S. Erturan, G. Hatemi, V. Hamuryudan (Istanbul, Turkey). Does anti TNF-α treatment increase tuberculosis risk?. Eur Respir J 2007; 30: Suppl. 51, 1773

Member's Comments

No comment yet.

Related content which might interest you: Who is at risk for active tuberculosis? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 Contact screening in tuberculosis. Can we identify those with higher risk? Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 Who are at risk for tuberculosis recurrence? Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011 Impact of anti tuberculosis therapy in plasma zinc status in childhood tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005 Contact screening in tuberculosis: can we identify those with higher risk? Source: Eur Respir J 2013; 41: 758-760 Year: 2013 Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario Source: Eur Respir J 2006; 28: Suppl. 50, 858s Year: 2006 Is it smoking a risk factor in tuberculosis? Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 The risk of ineffective MDR/XDR TB treatment, based on bedaquilin: factors and their influence Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Intensive tobacco smoking as a factor of the decrease of treatment effectiveness in patients with pulmonary tuberculosis (TB) Source: Eur Respir J 2005; 26: Suppl. 49, 157s Year: 2005 How does tobacco-smoking contribute to the tuberculosis burden? Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news? Year: 2007 Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008 The causes of ineffectiveness of treatment of tuberculosis in children Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005 Fenofibrate is associated with higher risk of mortality in patients with tuberculosis infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Attempt to estimate risk factors for drug resistance (DR) in tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 653s Year: 2005 Smoking is a risk factor for TB infection, but is it an additional mortality risk? Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007